From: Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis
Organ | %ID/g | Organ/blood ratio | ||||||
---|---|---|---|---|---|---|---|---|
EC2319 (n = 10) | Saline (n = 10) | P value | Treatment effect | EC2319 (n = 8) | Saline (n = 8) | P value | Treatment effect | |
Adrenal glands | 0.31 ± 0.09 | 0.35 ± 0.06 | 0.25 | ↓ | 5.92 ± 1.69 | 10.80 ± 2.19 | < 0.001 | ↓ |
Blood | 0.05 ± 0.02 | 0.03 ± 0.01 | 0.004 | ↑ | ND | ND | ND | ND |
Brain | 0.04 ± 0.01 | 0.02 ± 0.003 | < 0.001 | ↑ | 0.73 ± 0.13 | 0.59 ± 0.09 | 0.027 | ↑ |
Heart | 0.18 ± 0.08 | 0.20 ± 0.03 | 0.37 | ↓ | 3.35 ± 1.51 | 6.19 ± 0.85 | < 0.001 | ↓ |
Kidneys | 13.18 ± 4.39 | 6.17 ± 1.13 | < 0.001 | ↑ | 252.84 ± 84.26 | 170.46 ± 18.89 | 0.037 | ↑ |
Liver | 0.26 ± 0.07 | 0.47 ± 0.15 | 0.03 | ↓ | 4.89 ± 1.31 | 14.92 ± 4.85 | < 0.001 | ↓ |
Lungs | 0.16 ± 0.03 | 0.22 ± 0.03 | < 0.001 | ↓ | 3.03 ± 0.58 | 6.94 ± 0.79 | < 0.001 | ↓ |
Lymph node | 0.94 ± 0.25 | 0.88 ± 0.08 | 0.52 | ↑ | 17.96 ± 4.75 | 27.35 ± 2.01 | < 0.001 | ↓ |
Muscle | 0.11 ± 0.05 | 0.09 ± 0.01 | 0.12 | ↑ | 2.15 ± 0.89 | 2.66 ± 0.28 | 0.17 | ↓ |
Pancreas | 0.29 ± 0.06 | 0.36 ± 0.04 | 0.16 | ↓ | 5.59 ± 1.05 | 9.96 ± 1.42 | < 0.001 | ↓ |
Plasma | 0.09 ± 0.03 | 0.06 ± 0.02 | 0.01 | ↑ | 1.73 ± 0.49 | 1.95 ± 0.61 | 0.89 | ↓ |
Salivary gland | 1.01 ± 0.35 | 1.24 ± 0.21 | 0.10 | ↓ | 19.28 ± 6.74 | 38.39 ± 6.48 | < 0.001 | ↓ |
Skin | 0.23 ± 0.07 | 0.21 ± 0.08 | 0.69 | ↑ | 4.33 ± 1.32 | 5.99 ± 2.08 | 0.04 | ↓ |
Skull | 0.07 ± 0.03 | 0.15 ± 0.04 | < 0.001 | ↓ | 1.32 ± 0.54 | 4.81 ± 1.16 | < 0.001 | ↓ |
Small intestine | 0.56 ± 0.15 | 0.78 ± 0.10 | 0.002 | ↓ | 10.70 ± 2.87 | 24.30 ± 2.49 | < 0.001 | ↓ |
Spleen | 0.75 ± 0.31 | 1.83 ± 0.37 | < 0.001 | ↓ | 14.45 ± 5.88 | 55.95 ± 11.99 | < 0.001 | ↓ |
Urine | 3.00 ± 2.08 | 2.86 ± 0.02 | 0.32 | ↑ | 57.62 ± 39.86 | 92.25 ± 39.95 | 0.13 | ↓ |
White adipose | 0.05 ± 0.02 | 0.03 ± 0.01 | 0.004 | ↑ | 1.04 ± 0.17 | 1.45 ± 0.55 | 0.04 | ↓ |